Felling depressed because HRC is still walking free? Plz don't turn to Big Pharma for Help! Read below:

The FDA Ban of L-Tryptophan: Politics, Profits and Prozac

By Dean Wolfe Manders, Ph.D.

Copyright, All Rights Reserved

This article first appeared in "Social Policy", Vol. 26, No. 2 Winter 1995. Dr Manders has lectured and done extensive research on the medical politics of L-Tryptophan. The article also appeared in "Blazing Tattles" June 1996.

In the fall of 1989, the FDA recalled L-Tryptophan, an amino acid nutritional supplement, stating that it caused a rare and deadly flu-like condition (Eosinophilia-Myalgia Syndrome- EMS). On March 22, 1990, the FDA banned the public sale dietary of L-Tryptophan completely. This ban continues today.

On March 26, 1990, Newsweek featured a lead article praising the virtues of the anti-depressant drug Prozac. Its multi color cover displayed a floating, gigantic green and white capsule of Prozac with the caption: "Prozac: A Breakthrough drug for Depression."

The fact that the FDA ban of L-Tryptophan and the Newsweek Prozac cover story occurred within four days of each other went unnoticed by both the media and the public. Yet, to those who understand the effective properties of L-Tryptophan and Prozac, the concurrence seems "unbelievably coincidental." The link here is the brain neurotransmitter serotonin– a biochemical nerve signal conductor. The action of Prozac and L-Tryptophan are both involved with serotonin, but in totally different ways.

http://whale.to/a/manders.html